创伤性休克与心搏骤停急救复苏创新技术临床应用专家共识(2020版)  

Expert consensus on clinical application of innovative first-aid resuscitation technology for traumatic shock and cardiac arrest(The 2020 version)

作　　者：无 张思森 岳茂兴 王立祥[7] Zhang Sisen;Yue Maoring;Wang Liriang(Health emergency committee of Chinese Research Hospital Assocation;Cardiopulmonary Resuscitation Specialized Comite of Chinese Research Hospital Assocation;Cardiopulmonary Resuscitation Specialized Cotte of Henan Hospital Association,Zhengzhou 450003,China)

机构地区：[1]中国研究型医院学会卫生应急学专业委员会 [2]中国研究型医院学会心肺复苏学专业委员会 [3]河南省医院协会心肺复苏专业分会 [4]河南中医药大学人民医院 [5]南方医科大学附属郑州人民医院,郑州450003 [6]解放军第三〇六医院特种医学中心,北京100101 [7]解放军总医院第三医学中心,北京100039

出　　处：《河南外科学杂志》2020年第6期1-11,共11页Henan Journal of Surgery

基　　金：科技部“973”计划发展规划项目(2005CB522602);科技部科技支撑课题项目(2014BAL05B06);第三军医大学国家重点实验室开放课题项目(SKLKF201312);河南省科技惠民重点支持项目(152207310007);中国研究型医院学会科研立项(201702011);河南省医学科技攻关计划(省部共建)重点项目(2018010045);河南省医学重点学科建设支持项目(201626155);河南省科技惠民计划项目(152207310007);河南省中医药科研专项(2108ZY3017);江苏省卫生厅重大课题项目(Z201013);常州市基础应用研究课题项目(JC20140001)。

摘　　要：2019新型冠状病毒感染疾病(2019novelcoronavirus,COVID-19)已引起全球范围的重大破坏,SARS-CoV2仍在世界各国持续传播和局部暴发,给社会发展和经济复苏带来了巨大挑战,为科学做好疫情防控常态化下的创伤性休克和心搏骤停急救复苏临床工作,要对既定规则和流程进行修改和完善,去指导和规范人类的行为.针对多发伤急救复苏面临的挑战,是在常态化疫情防控和保证急救人员安全的前提下,对创伤性休克患者施救,使其获得生存机会.因此,为了规范化新冠疫情影响下创伤性休克及心搏搏骤停的临床救治技术培训与普及工作,中国研究型医院学会卫生应急学专业委员会、中国研究型医院学会心肺复苏学专业委员会、河南省医院协会心肺复苏专业分会共同制定了《新冠疫情影响下创伤性休克急救复苏新技术临床应用专家共识(2020)》.该共识对创伤性休克院前无法输血或血浆紧急情况下,解决了容量复苏晶胶液配比与搭配问题.高渗晶胶复合液救治创伤性休克,用量小,稳定血压效果好,可替代血及血制品,提高了转运到医院的安全性,为手术抢救提供了机会;同时,腹部提压CPR解决了创伤后心搏骤停不能实施传统胸外按压心肺复苏患者的救治难题,大大提高了院前创伤性休克患者的救治成功率.鉴于我国急救医疗的实际需求和胸部创伤禁忌行胸部CPR的特点,采取"政、产、学、研、用"相结合,腹部提压CPR研制成功并推广应用.本共识总结了迄今为止国内外已发表的关于创伤性休克与创伤性心搏骤停的科学证据,并基于我国国情,提出了创伤性休克急救复苏创新技术临床应用专家共识.本共识融入了国内外创伤性休克及CPR培训的学者智慧与理念,必将使我国创伤性休克与创伤性心搏骤停培训进入一个针对性强、起效快、副作用少、救治率高的新阶段.The global pandermic of coronavirus disease 2019(COVID-19)has caused significant woddwide disruption.The evolving and expanding outbreak of SARS-CoV2 infections has created important challenges to such resuscitation efforts and requires potential modifica-tions of established processes and practices.The challenge is to ensure that patients with or without COVID-19 who experience traumatic shock get the best possible chance of survival without compromi sing the safety of rescuers.To promote the clinical treatment technical training and pop-ularization of traumatic shock and cardiac arrest under the influence of the coronavirus disease COVID-19,cardiopulmonary resuscitation spe-cialized committee of Chinese research hospital,health emergency committee of Chinese research hospital association,cardiopulmonary resusci-tation specialized committee of Henan hospital association jointly established‘Expert consensus on the clinical application of innovative first-aid resuscitation technology for traumatic shock under the influence of the coronavirus disease 2019(COVID-19)’.This consensus has solved the problem of ratio and matching of volume resuscitated gel solution in the case of pre-hospital transfusion and plasma emergency of traumatie shock.Hypertonic gel compound liquid can treat traumatie shock with small dosage and good efect of stabilzing blood pressure.It can replace blood and blood products,improve the safety of transport to hospital,and provide an opportunity for life-saving surgery.At the same time,abdominal lifting and compression cardiopulmonary resuscitation(CPR)solved the difficulty of treating patients with post-traumatic cardiac arrest who cannot perform traditional chest compressive CPR,and greatly improved the success rate of pre-hospital treatment for patients with trau-matic shock.In view of the actual demand of emergency medical treat ment in China and the contraband of chest CPR for chest trauma,the combination of"administration,production,study,research and application"was adopted,and the CPR

关 键 词：创伤性休克 心搏骤停 复苏 专家共识 新冠肺炎 

分 类 号：R605.971[医药卫生—急诊医学] R541.78[医药卫生—外科学]